2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175

Human agency in social cognitive theory.

Bandura, A. (1989) · American Psychologist · doi:10.1037/0003-066x.44.9.1175 · Cited by 8,263

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140

Angiotensin-neprilysin inhibition versus enalapril in heart failure

McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382

2017 ESC/EACTS Guidelines for the management of valvular heart disease

Baumgartner, H., Falk, V., Bax, J. J., Bonis, M. D., Hamm, C. W., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Muñoz, D. R., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,356

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189

Dapagliflozin in Patients with Chronic Kidney Disease

Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618

Social Learning Theory and the Health Belief Model

Rosenstock, I. M., Strecher, V. J., & Becker, M. H. (1988) · Health Education Quarterly · doi:10.1177/109019818801500203 · Cited by 5,564

Cardiovascular and renal outcomes with empagliflozin in heart failure

Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022190 · Cited by 5,206

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

(1999) · The Lancet · doi:10.1016/s0140-6736(99)04440-2 · Cited by 5,141

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

Lechat, P. P., Brunhuber, K., Hofmann, R., Kuhn, P., Nesser, H., Slany, J., Weihs, W., Wiedermann, C. J., Wimmer, H., van Mieghem, W., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,922

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649

Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,507

Eplerenone in patients with systolic heart failure and mild symptoms

Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806640 · Cited by 3,017

Forecasting the Impact of Heart Failure in the United States

Heidenreich, P. A., Albert, N. M., Allen, L. A., Bluemke, D. A., Butler, J., Fonarow, G. C., Ikonomidis, J. S., Khavjou, O., Konstam, M. A., Maddox, T. M., et al. (2013) · Circulation Heart Failure · doi:10.1161/hhf.0b013e318291329a · Cited by 2,872

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563

Catheter Ablation for Atrial Fibrillation with Heart Failure

MARROUCHE, N. F., Brachmann, J., Andresen, D., Siebels, J., Boersma, L. V. A., Jordaens, L. J. L. M., Merkely, B. P., Pokushalov, E., Sanders, P., Proff, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1707855 · Cited by 2,514

A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart Failure

Rich, M. W., Beckham, V., Wittenberg, C., Leven, C. L., Freedland, K. E., & Carney, R. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331806 · Cited by 2,326

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease

Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H. M., Krieger, E. V., Mack, M. J., McLeod, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 2,110

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083

The Seattle Heart Failure Model

Levy, W. C., Mozaffarian, D., Linker, D. T., Sutradhar, S., Anker, S. D., Cropp, A. B., Anand, I. S., Maggioni, A. P., Burton, P. B. J., Sullivan, M. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.584102 · Cited by 2,024

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease

Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.007 · Cited by 1,941

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896

Sotagliflozin in patients with diabetes and recent worsening heart failure

Bhatt, D. L., Szarek, M., Steg, P. G., Cannon, C. P., Leiter, L. A., McGuire, D. K., Lewis, J. B., Riddle, M. C., Voors, A. A., Metra, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2030183 · Cited by 1,868

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

Obadia, J., Messika–Zeitoun, D., Leurent, G., Iung, B., Bonnet, G., Piriou, N., Lefèvre, T., Piot, C. A., Rouleau, F., Carrié, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805374 · Cited by 1,851

Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure

Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial

Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., Strickland, W., Neelagaru, S., Raval, N., Krueger, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60101-3 · Cited by 1,744

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

Kosiborod, M. N., Abildstrøm, S. Z., Borlaug, B. A., Butler, J., Rasmussen, S., Davies, M., Hovingh, G. K., Kitzman, D. W., Lindegaard, M. L., Møller, D. V., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2306963 · Cited by 1,669

Medication Adherence: Its Importance in Cardiovascular Outcomes

Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488

The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update

Mehra, M. R., Canter, C. E., Hannan, M. M., Semigran, M. J., Uber, P. A., Baran, D. A., Danziger‐Isakov, L. A., Kirklin, J. K., Kirk, R., Kushwaha, S. S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.023 · Cited by 1,424

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: A meta-analysis of the EMPEROR-Reduced and DAPA-HF trials

Zannad, F., Ferreira, J. P., Pocock, S. J., Anker, S. D., Butler, J., Filippatos, G., Brueckmann, M., Ofstad, A. P., Pfarr, E., Jamal, W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31824-9 · Cited by 1,408

The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary

Feldman, D. S., Pamboukian, S. V., Teuteberg, J. J., Birks, E. J., Lietz, K., Moore, S. A., Morgan, J. A., Arabía, F. A., Bauman, M. E., Buchholz, H. W., et al. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.09.013 · Cited by 1,384

Vericiguat in patients with heart failure and reduced ejection fraction

Armstrong, P. W., Pieske, B., Anstrom, K. J., Ezekowitz, J., Hernandez, A. F., Butler, J., Lam, C. S. P., Ponikowski, P., Voors, A. A., Jia, G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915928 · Cited by 1,358

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure

Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., Kubo, S. H., Narahara, K. A., Ingersoll, H., Krueger, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2807 · Cited by 1,303

Angiotensin-neprilysin inhibition in acute decompensated heart failure

Velazquez, E. J., Morrow, D. A., DeVore, A. D., Duffy, C. I., Ambrosy, A. P., McCague, K., Rocha, R., & Braunwald, E. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812851 · Cited by 1,260

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

Ponikowski, P. P., van Veldhuisen, D. J., Colet, J. C., Ertl, G., Michel Komajda, N., VIu, M., McDonagh, T. A., Parkhomenko, A. N., Tavazzi, L., Levesque, V., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu385 · Cited by 1,240

Telemonitoring in patients with heart failure

Chaudhry, S. I., Mattera, J. A., Curtis, J. P., Spertus, J. A., Herrin, J., Lin, Z., Phillips, C. O., Hodshon, B. V., Cooper, L. S., & Krumholz, H. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1010029 · Cited by 1,232

Frailty Assessment in the Cardiovascular Care of Older Adults

Afilalo, J., Alexander, K. P., Mack, M. J., Maurer, M. S., Green, P., Allen, L. A., Popma, J. J., Ferrucci, L., & Forman, D. E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.070 · Cited by 1,173

Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure

Cowie, M., Woehrle, H., Wegscheider, K., Angermann, C., d’Ortho, M., Erdmann, E., Levy, P. A., Simonds, A. K., Somers, V. K., Zannad, F. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506459 · Cited by 1,126

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Mebazaa, A., Davison, B., Chioncel, O., Cohen-Solal, A., Diaz, R., Filippatos, G., Metra, M., Ponikowski, P., Sliwa, K., Voors, A. A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02076-1 · Cited by 1,123

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

Mancia, G., Rea, F., Ludergnani, M., Apolone, G., & Corrao, G. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006923 · Cited by 1,087

Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers

Arora, S., Thornton, K., Murata, G. H., Deming, P., Kalishman, S. G., Dion, D., Parish, B. S., Burke, T., Pak, W., Dunkelberg, J. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009370 · Cited by 1,077

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

Reynolds, H. R., Adhikari, S., Pulgarin, C., Troxel, A. B., Iturrate, E., Johnson, S. B., Hausvater, A., Newman, J. D., Berger, J. S., Bangalore, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008975 · Cited by 1,068

Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006

Mehra, M. R., KOBASHIGAWA, J. A., Starling, R. C., Russell, S., Uber, P. A., Parameshwar, J. K., Mohaçsi, P., AUGUSTINE, S., Aaronson, K. D., & Barr, M. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.06.008 · Cited by 961

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation

Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction

Maddox, T. M., Januzzi, J. L., Allen, L. A., Breathett, K. K., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Lindenfeld, J., Masoudi, F. A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.022 · Cited by 872

Decision Making in Advanced Heart Failure

Allen, L. A., Stevenson, L. W., Grady, K. L., Goldstein, N. E., Matlock, D. D., Arnold, R. M., Cook, N. R., Felker, G. M., Francis, G. S., Hauptman, P. J., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31824f2173 · Cited by 833

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Ponikowski, P. P., Kirwan, B., Anker, S. D., McDonagh, T. A., Dorobanţu, M., Dróżdż, J., Fabien, V., Filippatos, G. S., Göhring, U., Keren, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32339-4 · Cited by 800

Anemia and Mortality in Heart Failure Patients

Groenveld, H. F., Januzzi, J. L., Damman, K., van Wijngaarden, J., Hillege, H. L., van Veldhuisen, D. J., & van der Meer, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.061 · Cited by 764

Full Coverage for Preventive Medications after Myocardial Infarction

Choudhry, N. K., Avorn, J., Glynn, R. J., Antman, E. M., Schneeweiß, S., Toscano, M., Reisman, L., Fernandes, J. F., Spettell, C. M., Lee, J. L.-Y., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1107913 · Cited by 745

Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial

Hindricks, G., Táborský, M., Glikson, M., Heinrich, U., Schumacher, B., Katz, A., Brachmann, J., Lewalter, T., Goette, A., Block, M. S., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61176-4 · Cited by 742

Iron deficiency in chronic heart failure: an international pooled analysis

Klip, I. T., Comin-Colet, J., Voors, A. A., Ponikowski, P., Enjuanes, C., Banasiak, W., Lok, D. J., Rosentryt, P., Torrens, A., Polonski, L., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.01.017 · Cited by 736

Thirty-Day Readmission Rates for Medicare Beneficiaries by Race and Site of Care

Joynt, K. E. (2011) · JAMA · doi:10.1001/jama.2011.123 · Cited by 729

Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America

Bozkurt, B., Ahmad, T., Alexander, K. M., Baker, W. L., Bosak, K., Breathett, K. K., Fonarow, G. C., Heidenreich, P. A., Ho, J. E., Hsich, E., et al. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2023.07.006 · Cited by 720

Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart Failure: The Telemedical Interventional Monitoring in Heart Failure Study

Koehler, F., Winkler, S., Schieber, M., Sechtem, U., Stangl, K., Böhm, M., Boll, H., Baumann, G., Honold, M., Koehler, K., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.018473 · Cited by 716

Intrathoracic Impedance Monitoring in Patients With Heart Failure

Yu, C., Wang, L., Chau, E. M. C., Chan, R. H.-W., Kong, S., TANG, M., Christensen, J., Stadler, R. W., & Lau, C. (2005) · Circulation · doi:10.1161/circulationaha.104.492207 · Cited by 708

Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology

Seferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708

Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure: A Systematic Review and Meta-analysis

Feltner, C., Jones, C. D., Cené, C. W., Zheng, Z.-J., Sueta, C. A., Coker-Schwimmer, E. J. L., Arvanitis, M., Lohr, K. N., Middleton, J. C., & Jonas, D. E. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0083 · Cited by 681

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

Vaduganathan, M., Claggett, B. L., Jhund, P. S., Cunningham, J. W., Ferreira, J. P., Zannad, F. M., Packer, M., Fonarow, G. C., McMurray, J. J. V., & Solomon, S. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30748-0 · Cited by 681

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial

Halliday, B. P., Wassall, R., Lota, A. S., Khalique, Z., Gregson, J., Newsome, S., Jackson, R. W., Rahneva, T., Wage, R., Smith, G. C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32484-x · Cited by 657

Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000691 · Cited by 639

Interventions to Improve Medication Adherence

Kini, V., & Ho, P. M. (2018) · JAMA · doi:10.1001/jama.2018.19271 · Cited by 638

Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction

Januzzi, J. L., Prescott, M. F., Butler, J., Felker, G. M., Maisel, A. S., McCague, K., Camacho, A., Piña, I. L., Rocha, R. A., Shah, A. M., et al. (2019) · JAMA · doi:10.1001/jama.2019.12821 · Cited by 634

Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure

Packer, M., Califf, R. M., Konstam, M. A., Krum, H., McMurray, J. J. V., Rouleau, J. L., & Swedberg, K. B. (2002) · Circulation · doi:10.1161/01.cir.0000029801.86489.50 · Cited by 615

Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors

Zelniker, T. A., & Braunwald, E. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.031 · Cited by 596

Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

Swedberg, K. B., Young, J. B., Anand, I. S., Cheng, S., Desai, A. S., Díaz, R., Maggioni, A. P., McMurray, J. J. V., O’Connor, C. J., Pfeffer, M. A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214865 · Cited by 589

Discharge Education Improves Clinical Outcomes in Patients With Chronic Heart Failure

Koelling, T. M., Johnson, M. L., Cody, R. J., & Aaronson, K. D. (2005) · Circulation · doi:10.1161/01.cir.0000151811.53450.b8 · Cited by 564

Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction

Santos‐Gallego, C. G., Vargas-Delgado, A. P., Requena-Ibáñez, J. A., García‐Ropero, Á., MANCINI, D. M., Pinney, S., Macaluso, F., Sartori, S., Roqué, M., Sabatel-Pérez, F., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.008 · Cited by 555

Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction

Felker, G. M., Anstrom, K. J., Adams, K. F., Ezekowitz, J. A., Fiuzat, M., Miller, N. H., Januzzi, J. L., Mark, D. B., Piña, I. L., Passmore, G., et al. (2017) · JAMA · doi:10.1001/jama.2017.10565 · Cited by 554

2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction

Kittleson, M. M., Panjrath, G. S., Amancherla, K., Davis, L. L., Deswal, A., Dixon, D. L., Januzzi, J. L., & Yancy, C. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.393 · Cited by 554

The prevalence of frailty in heart failure: A systematic review and meta-analysis

Denfeld, Q. E., Winters‐Stone, K. M., Mudd, J. O., Gelow, J. M., Kurdi, S. M., & Lee, C. S. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.01.153 · Cited by 507

Titration of medical therapy for heart failure with reduced ejection fraction

Greene, S. J., Fonarow, G. C., DeVore, A. D., Sharma, P. P., Vaduganathan, M., Albert, N. M., Duffy, C. I., Hill, C. L., McCague, K., Patterson, J. H., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.015 · Cited by 500

Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency

Lewis, G. D., Malhotra, R. K., Hernandez, A. F., McNulty, S. E., Smith, A. L., Felker, G. M., Tang, W. H. W., LaRue, S., Redfield, M. M., Semigran, M. J., et al. (2017) · JAMA · doi:10.1001/jama.2017.5427 · Cited by 490

Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure

Fox, K., Ford, I., Steg, P. G., Tardif, J.-C., Tendera, M., & Ferrari, R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406430 · Cited by 486

Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure

McAlister, F. A., Wiebe, N., Ezekowitz, J. A., Leung, A. A., & Armstrong, P. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00006 · Cited by 481

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes

Das, S. R., Everett, B. M., Birtcher, K. K., Brown, J. M., Januzzi, J. L., Kalyani, R. R., Kosiborod, M., Magwire, M., Morris, P. B., Neumiller, J. J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.037 · Cited by 466

Thinking Outside the Pillbox — Medication Adherence as a Priority for Health Care Reform

Cutler, D., & Everett, W. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1002305 · Cited by 459

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)

Lee, M. M. Y., Brooksbank, K. J. M., Wetherall, K., Mangion, K., Roditi, G., Campbell, R. T., Berry, C., Chong, V., Coyle, L., Docherty, K. F., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.052186 · Cited by 441

Health Literacy and Outcomes Among Patients With Heart Failure

Peterson, P. N. (2011) · JAMA · doi:10.1001/jama.2011.512 · Cited by 438

Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial

Lindenfeld, J. M., Zile, M. R., Desai, A. S., Bhatt, K. A., Ducharme, A., Horstmanshof, D., Krim, S. R., Maisel, A. S., Mehra, M. R., Paul, S. C., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01754-2 · Cited by 433

A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission

Kasper, E. K., Gerstenblith, G., Hefter, G. B., Anden, E. V., Brinker, J., Thiemann, D. R., Terrin, M. L., Forman, S. A., & Gottlieb, S. H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01761-2 · Cited by 429

Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta‐Analysis of Controlled Trials

Ruppar, T. M., Cooper, P. S., Mehr, D. R., Delgado, J. M., & Dunbar‐Jacob, J. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002606 · Cited by 427

Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices

Fonarow, G. C., Albert, N. M., Curtis, A. B., Stough, W. G., Gheorghiade, M., Heywood, J. T., McBride, M. L., Inge, P. J., Mehra, M. R., O’Connor, C. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.934471 · Cited by 425

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

Nassif, M. E., Windsor, S. L., Tang, F., Khariton, Y., Husain, M., Inzucchi, S. E., McGuire, D. K., Pitt, B., Scirica, B. M., Austin, B., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.042929 · Cited by 424

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Kalra, P. R., Cleland, J. G. F., Petrie, M. C., Thomson, E. A., Kalra, P. A., Squire, I. B., Ahmed, F. Z., Al‐Mohammad, A., Cowburn, P. J., Foley, P. W. X., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02083-9 · Cited by 421

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)

Mehta, N., Kalra, A., Nowacki, A. S., Anjewierden, S., Han, Z., Bhat, P., Rubio, A. C., Jacob, M. S., Procop, G. W., Harrington, S. M., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1855 · Cited by 411

Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

de Abajo, F. J., Rodríguez‐Martín, S., Lerma, V., Mejía-Abril, G. P., Aguilar, M., García-Luque, A., Laredo, L., Laosa, O., Centeno-Soto, G. A., Gálvez, M. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31030-8 · Cited by 409

2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Lloyd‐Jones, D. M., Morris, P. B., Ballantyne, C. M., Birtcher, K. K., Daly, D. D., DePalma, S. M., Minissian, M., Orringer, C. E., & Smith, S. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.745 · Cited by 398

Which Components of Heart Failure Programmes are Effective? A Systematic Review and Meta-Analysis of the Outcomes of Structured Telephone Support or Telemonitoring as the Primary Component of Chronic Heart Failure Management in 8323 Patients: Abridged Cochrane Review

Inglis, S. C., Clark, R. A., McAlister, F. A., Stewart, S., & Cleland, J. G. F. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr039 · Cited by 378

Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis

Conn, V. S., & Ruppar, T. M. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.03.008 · Cited by 367

Assessing Medication Adherence in the Elderly: Which Tools to Use in Clinical Practice?

MacLaughlin, E. J., Raehl, C. L., Treadway, A. K., Sterling, T. L., Zoller, D. P., & Bond, C. A. (2005) · Drugs & Aging · doi:10.2165/00002512-200522030-00005 · Cited by 363

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke

Warner, J. J., Harrington, R. A., Sacco, R. L., & Elkind, M. S. V. (2019) · Stroke · doi:10.1161/strokeaha.119.027708 · Cited by 361

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study

Wachter, R., Senni, M., Belohlavek, J., Straburzynska-Migaj, E., Witte, K. K., Kobalava, Z., Fonseca, C., Goncalvesova, E., Cavusoglu, Y., Fernandez, A., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1498 · Cited by 354

Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee

Fang, J. C., Ewald, G. A., Allen, L. A., Butler, J., Canary, C. A. W., Colvin, M. M., Dickinson, M. G., Levy, P. D., Stough, W. G., Sweitzer, N. K., et al. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.04.013 · Cited by 351

Addressing social determinants of health in the care of patients with heart failure: a scientific statement from the American Heart Association

White-Williams, C., Rossi, L. P., Bittner, V. A., Driscoll, A., Durant, R. W., Granger, B. B., Graven, L. J., Kitko, L., Newlin, K., Shirey, M., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000767 · Cited by 349

2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure

Hollenberg, S. M., Stevenson, L. W., Ahmad, T., Amin, V. J., Bozkurt, B., Butler, J., Davis, L. L., Drazner, M. H., Kirkpatrick, J. N., Peterson, P. N., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.001 · Cited by 344

Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation

Kang, D., Park, S., Shin, S., Hong, G., Lee, S., Kim, M., Yun, S., Song, J., Park, S. W., & Kim, J. (2019) · Circulation · doi:10.1161/circulationaha.118.037077 · Cited by 341

Heart Failure With Recovered Left Ventricular Ejection Fraction

Wilcox, J. E., Fang, J. C.-T., Margulies, K. B., & Mann, D. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.075 · Cited by 336

Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates

Mohebi, R., Chen, C., Ibrahim, N. E., McCarthy, C. P., Gaggin, H. K., Singer, D. E., Hyle, E. P., Wasfy, J. H., & Januzzi, J. L. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.05.033 · Cited by 319

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF

Jhund, P. S., Solomon, S. D., Docherty, K. F., Heerspink, H. J. L., Anand, I. S., Böhm, M., Chopra, V., de Boer, R. A., Desai, A. S., Ge, J., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050391 · Cited by 307

Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta‐Analysis

Yang, X., Lupón, J., Vidán, M. T., Ferguson, C., Gastelurrutia, P., Newton, P. J., Macdonald, P. S., Bueno, H., Bayés‐Genís, A., Woo, J., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008251 · Cited by 306

Patient Empowerment and its neighbours: Clarifying the boundaries and their mutual relationships

Fumagalli, L. P., Radaelli, G., Lettieri, E., Bertele, P., & Masella, C. (2014) · Health Policy · doi:10.1016/j.healthpol.2014.10.017 · Cited by 304

Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure

Rich, M. W., Gray, D. B., Beckham, V., Wittenberg, C., & Luther, P. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00172-6 · Cited by 296

2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction

Yancy, C. W., Januzzi, J. L., Allen, L. A., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Jessup, M. L., Lindenfeld, J., Maddox, T. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.025 · Cited by 284

Impact of Medication Nonadherence on Hospitalizations and Mortality in Heart Failure

Fitzgerald, A. A., Powers, J. D., Ho, P. M., Maddox, T. M., Peterson, P. N., Allen, L. A., Masoudi, F. A., Magid, D. J., & Havranek, E. P. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.04.011 · Cited by 282

Understanding the Complexity of Heart Failure Risk and Treatment in Black Patients

Nayak, A., Hicks, A. J., & Morris, A. A. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007264 · Cited by 275

Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial

Brugts, J. J., Radhoe, S. P., Clephas, P. R. D., Aydin, D., van Gent, M. W. F., Szymanski, M. K., Rienstra, M., van den Heuvel, M., Fonseca, C. A. M., Linssen, G. C. M., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00923-6 · Cited by 266

Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?

Swedberg, K. B., Michel Komajda, N., Böhm, M., BORER, J. S., Robertson, M., Tavazzi, L., & Ford, I. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.020 · Cited by 262

Review and Analysis of Existing Mobile Phone Apps to Support Heart Failure Symptom Monitoring and Self-Care Management Using the Mobile Application Rating Scale (MARS)

Creber, R. M., Maurer, M. S., Turchioe, M. R., Hiraldo, G., Hickey, K. T., & Iribarren, S. (2016) · JMIR mhealth and uhealth · doi:10.2196/mhealth.5882 · Cited by 255

Ferric Carboxymaltose in Heart Failure with Iron Deficiency

Mentz, R. J., Garg, J., Rockhold, F. W., Butler, J., Pasquale, C. G. D., Ezekowitz, J. A., Lewis, G. D., O’Meara, E., Ponikowski, P. P., Troughton, R. W., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2304968 · Cited by 254

Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study

Böhm, M., Borer, J., Ford, I., Gonzalez-Juanatey, J. R., Komajda, M., Lopez-Sendon, J., Reil, J.-C., Swedberg, K., & Tavazzi, L. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0467-8 · Cited by 248

Initiating Sacubitril/Valsartan (LCZ696) in Heart Failure: Results of TITRATION, a Double-Blind, Randomized Comparison of Two Uptitration Regimens

Senni, M., McMurray, J. J. V., Wachter, R., McIntyre, H. F., Reyes, A., Majerčák, I., Andreka, P. G., Shehova-Yankova, N. S., Anand, I. S., Yılmaz, M. B., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.548 · Cited by 241

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial

Butler, J., Anker, S. D., Lund, L. H., Coats, A. J. S., Filippatos, G. S., Siddiqi, T. J., Friede, T., Fabien, V., Kosiborod, M., Metra, M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac401 · Cited by 238

Health-Related Quality of Life Outcomes in PARADIGM-HF

Lewis, E. F., Claggett, B. L., McMurray, J. J. V., Packer, M., Lefkowitz, M. P., Rouleau, J. L., Liu, J., Shi, V. C., Zile, M. R., Desai, A. S., et al. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003430 · Cited by 221

Deprescribing in Older Adults With Cardiovascular Disease

Krishnaswami, A., Steinman, M. A., Goyal, P., Zullo, A. R., Anderson, T. S., Birtcher, K. K., Goodlin, S. J., Maurer, M. S., Alexander, K. P., Rich, M. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.467 · Cited by 212

Guidance for Timely and Appropriate Referral of Patients With Advanced Heart Failure: A Scientific Statement From the American Heart Association

Morris, A. A., Khazanie, P., Drazner, M. H., Albert, N. M., Breathett, K. K., Cooper, L. B., Eisen, H. J., O’Gara, P. T., & Russell, S. D. (2021) · Circulation · doi:10.1161/cir.0000000000001016 · Cited by 210

Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice

Ghazi, L., Yamamoto, Y., Riello, R. J., Coronel-Moreno, C., Martin, M. C., O’Connor, K. D., Simonov, M., Huang, J., Olufade, T. O., MCDERMOTT, J. J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.338 · Cited by 210

Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure—Optimizing Therapy With the Need for Speed

Greene, S. J., Butler, J., & Fonarow, G. C. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.0496 · Cited by 209

Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation

Asch, F. M., Grayburn, P. A., Siegel, R. J., Kar, S., Lim, D. S., Zaroff, J. G., Mishell, J. M., Whisenant, B. K., Mack, M. J., Lindenfeld, J. M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.017 · Cited by 207

Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction

Solomon, S. D., Claggett, B. L., Desai, A. S., Packer, M., Zile, M. R., Swedberg, K. B., Rouleau, J. L., Shi, V. C., Starling, R. C., Kozan, Ö., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002744 · Cited by 206

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan

Myhre, P. L., Vaduganathan, M., Claggett, B. L., Packer, M., Desai, A. S., Rouleau, J. L., Zile, M. R., Swedberg, K. B., Lefkowitz, M. P., Shi, V. C., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.018 · Cited by 204

Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America

Gorodeski, E. Z., Goyal, P., Cox, Z. L., Thibodeau, J. T., Reay, R. E., Rasmusson, K., Rogers, J. G., & Starling, R. C. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.04.008 · Cited by 201

Effect of Mobile Health Interventions on the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis

Gandhi, S., Chen, S., Hong, L., Sun, K., Gong, E., Li, C., Yan, L. L., & Schwalm, J.-D. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.08.017 · Cited by 196

Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis

Yedlapati, S. H., Khan, S. U., Talluri, S., Lone, A. N., Khan, M. Z., Khan, M. S., Návar, A. M., Gulati, M., Johnson, H. M., Baum, S. J., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019636 · Cited by 187

2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation.

Bonow, R., O'Gara, P., Adams, D., Badhwar, V., Bavaria, J., Elmariah, S., Hung, J., Lindenfeld, J., Morris, A., Satpathy, R., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.005 · Cited by 184

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

Butler, J., Anker, S. D., Filippatos, G., Khan, M. S., Ferreira, J. P., Pocock, S. J., Giannetti, N., Januzzi, J. L., Piña, I. L., Lam, C. S. P., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa1007 · Cited by 183

Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure

Vardeny, O., Miller, R., & Solomon, S. D. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.09.001 · Cited by 182

Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring

Costanzo, M. R., Stevenson, L. W., Adamson, P. B., Desai, A. S., Heywood, J. T., Bourge, R. C., Bauman, J. G., & Abraham, W. T. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2015.11.011 · Cited by 177

Reduced Loop Diuretic Use in Patients Taking Sacubitril/Valsartan Compared with Enalapril: The PARADIGM-HF Trial

Vardeny, O., Claggett, B. L., Kachadourian, J., Desai, A. S., Packer, M., Rouleau, J. L., Zile, M. R., Swedberg, K. B., Lefkowitz, M. P., Shi, V. C., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1402 · Cited by 175

Evaluation for Heart Transplantation and LVAD Implantation

Guglin, M. E., Zucker, M. J., Borlaug, B. A., Breen, E., Cleveland, J. C., Johnson, M. R., Panjrath, G. S., Patel, J. K., Starling, R. C., & Bozkurt, B. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.034 · Cited by 168

Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure

Ferreira, J. P., Zannad, F. M., Pocock, S., Anker, S. D., Butler, J., Filippatos, G. S., Brueckmann, M., Jamal, W., Steubl, D., Schueler, E., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.01.044 · Cited by 168

The Complexity and Cost of Drug Regimens of Older Patients Hospitalized With Heart Failure in the United States, 1998-2001

Masoudi, F. A., Baillie, C. A., Wang, Y., Bradford, W. D., Steiner, J. F., Havranek, E. P., Foody, J. M., & Krumholz, H. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.18.2069 · Cited by 168

Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry

Echouffo-Tcheugui, J. B., Xu, H., DeVore, A. D., Schulte, P. J., Butler, J., Yancy, C. W., Bhatt, D. L., Hernandez, A. F., Heidenreich, P. A., & Fonarow, G. C. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.07.025 · Cited by 160

Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction

Gaziano, T. A., Fonarow, G. C., Claggett, B. L., Chan, W. W., Deschaseaux, C., Turner, S. J., Rouleau, J. L., Zile, M. R., McMurray, J. J. V., & Solomon, S. D. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1747 · Cited by 157

Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction

Martens, P., Nuyens, D., Rivero‐Ayerza, M., Herendael, H. V., Vercammen, J., Ceyssens, W., Luwel, E., Dupont, M., & Müllens, W. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01440-y · Cited by 155

Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19

Bhatt, A. S., Jering, K., Vaduganathan, M., Claggett, B. L., Cunningham, J. W., Rosenthal, N. A., Signorovitch, J., Thune, J. J., Vardeny, O., & Solomon, S. D. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.11.003 · Cited by 150

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)

Serenelli, M., Böhm, M., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., DeMets, D. L., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa496 · Cited by 138

“I Need Help”—A mnemonic to aid timely referral in advanced heart failure

Baumwol, J. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.02.010 · Cited by 135

Intravenous Iron in Patients with Heart Failure and Iron Deficiency: An Updated Meta-Analysis

Graham, F. J., Pellicori, P., Kalra, P. R., Ford, I., Bruzzese, D., & Cleland, J. G. F. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2810 · Cited by 133

The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure

Ebner, N., Jankowska, E. A., Ponikowski, P., Lainscak, M., Elsner, S., Sliziuk, V., Steinbeck, L., Kube, J., Bekfani, T., Scherbakov, N., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.11.178 · Cited by 131

Impact of Heart Failure on the Clinical Course and Outcomes of Patients Hospitalized for COVID-19. Results of the Cardio-COVID-Italy Multicentre Study

Tomasoni, D., Inciardi, R. M., Lombardi, C., Tedino, C., Agostoni, P., Ameri, P., Barbieri, L., Bellasi, A., Camporotondo, R., Canale, C., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2052 · Cited by 128

African Americans Are Less Likely to Receive Care by a Cardiologist During an Intensive Care Unit Admission for Heart Failure

Breathett, K., Liu, W. G., Allen, L. A., Daugherty, S. L., Blair, I. V., Jones, J., Grunwald, G. K., Moss, M., Kiser, T. H., Burnham, E., et al. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.02.015 · Cited by 125

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial

Doehner, W., Anker, S. D., Butler, J., Zannad, F. M., Filippatos, G. S., Ferreira, J. P., Salsali, A., Kaempfer, C., Brueckmann, M., Pocock, S., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac320 · Cited by 124

Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction

Lowrie, R., Mair, F. S., Greenlaw, N., Forsyth, P., Jhund, P. S., McConnachie, A., Rae, B., & McMurray, J. J. V. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr433 · Cited by 117

Unintentional non-adherence and belief in medicines in older adults

Unni, E., & Farris, K. B. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2010.05.006 · Cited by 116

The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure

Eggink, R. N., Lenderink, A. W., Widdershoven, J. W. M. G., & van den Bemt, P. M. L. A. (2010) · Pharmacy World & Science · doi:10.1007/s11096-010-9433-6 · Cited by 116

Brain Natriuretic Peptide-Guided Treatment does not Improve Morbidity and Mortality in Extensively Treated Patients with Chronic Heart Failure: Responders to Treatment have a Significantly Better Outcome

Karlström, P., Alehagen, U., Boman, K., & Dahlström, U. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr078 · Cited by 108

Effect of Influenza on Outcomes in Patients With Heart Failure

Panhwar, M. S., Kalra, A., Gupta, T., Kolte, D. S., Khera, S., Bhatt, D. L., & Ginwalla, M. B. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2018.10.011 · Cited by 108

Temporal Trends in Decompensated Heart Failure and Outcomes During COVID-19: A Multisite Report from Heart Failure Referral Centres in London

Cannata, A. N., Bromage, D. I., Rind, I. A., Gregorio, C., Bannister, C., Albarjas, M., Piper, S. E., Shah, A. M., & McDonagh, T. A. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1986 · Cited by 106

Association Between Poorer Cognitive Function and Reduced Objectively Monitored Medication Adherence in Patients With Heart Failure

Dolansky, M. A., Hawkins, M. A. W., Schaefer, J. T., Sattar, A., Gunstad, J., Redle, J. D., Josephson, R., Moore, S. M., & Hughes, J. W. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.002475 · Cited by 105

Social Determinants of Health and 90‐Day Mortality After Hospitalization for Heart Failure in the REGARDS Study

Sterling, M. R., Ringel, J. B., Pinheiro, L. C., Safford, M. M., Levitan, E. B., Phillips, E., Brown, T. M., & Goyal, P. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014836 · Cited by 101

Elimination of Early Rehospitalization in a Randomized, Controlled Trial of Multidisciplinary Care in a High-Risk, Elderly Heart Failure Population: The Potential Contributions of Specialist Care, Clinical Stability and Optimal Angiotensin-Converting Enzyme Inhibitor Dose at Discharge

McDonald, K., Ledwidge, M. T., Cahill, J., Kelly, J., Quigley, P. J., MAURER, B. J., Begley, F., Ryder, M., Travers, B., Timmons, L., et al. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00134-3 · Cited by 95

Heart Failure as a Newly Approved Diagnosis for Cardiac Rehabilitation

Forman, D. E., Sanderson, B., Josephson, R., Raikhelkar, J., & Bittner, V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.052 · Cited by 91

Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures

Allen, L. A., Fonarow, G. C., Liang, L., Schulte, P. J., Masoudi, F. A., Rumsfeld, J. S., Ho, P. M., Eapen, Z. J., Hernandez, A. F., Heidenreich, P. A., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.014281 · Cited by 89

Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)

Januzzi, J. L., Butler, J., Fombu, E., Maisel, A. S., McCague, K., Piña, I. L., PRESCOTT, M. F., Riebman, J. B., & Solomon, S. D. (2018) · American Heart Journal · doi:10.1016/j.ahj.2017.12.021 · Cited by 89

Improvement in Structural and Functional Echocardiographic Parameters During Chronic Heart Failure Therapy Guided by Natriuretic Peptides: Mechanistic Insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) Study

Weiner, R. B., Baggish, A. L., Chen‐Tournoux, A., Marshall, J. E., Gaggin, H. K., Bhardwaj, A., Mohammed, A. A., Rehman, S., Barajas, L. J., Barajas, J. A., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs180 · Cited by 84

Excess 30-Day Heart Failure Readmissions and Mortality in Black Patients Increases With Neighborhood Deprivation

Patel, S. A., Krasnow, M. R., Long, K., Shirey, T. E., Dickert, N. W., & Morris, A. A. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007947 · Cited by 83

Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial

Loeb, M. B., Roy, A., Dokainish, H., Dans, A., Palileo‐Villanueva, L. M., Karaye, K. M., Zhu, J., Liang, Y., Goma, F. M., Damasceno, A. A. M., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00432-6 · Cited by 83

Angiotensin receptor-neprilysin inhibition with LCZ696: a novel approach for the treatment of heart failure

Langenickel, T., & Dole, W. P. (2012) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.11.002 · Cited by 83

Effect of Out‐of‐Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE)

Karter, A. J., Parker, M. M., Solomon, M. D., Lyles, C. R., Adams, A. S., Moffet, H. H., & Reed, M. (2017) · Health Services Research · doi:10.1111/1475-6773.12700 · Cited by 82

Race/Ethnicity, Disability, and Medication Adherence Among Medicare Beneficiaries with Heart Failure

Zhang, Y., & Baik, S. H. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2692-x · Cited by 81

Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial

Velazquez, E. J., Morrow, D. A., DeVore, A. D., Ambrosy, A. P., Duffy, C. I., McCague, K., Hernandez, A. F., Rocha, R. A., & Braunwald, E. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.01.004 · Cited by 76

Success of a Multidisciplinary Heart Failure Clinic for Initiation and Up-Titration of Key Therapeutic Agents

Jain, A., Mills, P. G., Nunn, L. M., Butler, J., Luddington, L., Ross, V., Cliffe, P., Ranjadayalan, K., & Timmis, A. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.09.009 · Cited by 75

Design and Performance of a Multisensor Heart Failure Monitoring Algorithm: Results From the Multisensor Monitoring in Congestive Heart Failure (MUSIC) Study

Anand, I. S., Tang, W. H. W., Greenberg, B., Chakravarthy, N., Libbus, I., & Katra, R. P. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.01.009 · Cited by 72

Impact of Systolic Blood Pressure on the Safety and Tolerability of Initiating and Up-Titrating Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the TITRATION Study

Senni, M., McMurray, J. J. V., Wachter, R., McIntyre, H. F., Anand, I. S., Duino, V., Sarkar, A., Shi, V. C., & Charney, A. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1054 · Cited by 72

Factors Related to Physician Clinical Decision-Making for African-American and Hispanic Patients: a Qualitative Meta-Synthesis

Breathett, K. K., Jones, J., Lum, H. D., Koonkongsatian, D., Jones, C. D., Sanghvi, U. J., Hoffecker, L., McEwen, M. M., Daugherty, S. L., Blair, I. V., et al. (2018) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-018-0468-z · Cited by 69

Modulation of cGMP in Heart Failure: A New Therapeutic Paradigm

Boerrigter, G., Lapp, H., & Burnett, J. C. J. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68964-5_21 · Cited by 69

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes

Essien, U. R., Singh, B., Swabe, G., Johnson, A. E., Eberly, L. A., Wadhera, R. K., Breathett, K., Vaduganathan, M., & Magnani, J. W. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.16290 · Cited by 69

NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial

Adamo, M., Pagnesi, M., Mebazaa, A., Davison, B. A., Edwards, C., Tomasoni, D., Arrigo, M., Barros, M., Biegus, J., Čelutkienė, J., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad335 · Cited by 68

Self-management in heart failure: where have we been and where should we go?

Gardetto, N. J. (2011) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s8174 · Cited by 65

Exploring Patients' Reasons for Discontinuance of Heart Medications

Garavalia, L. S., Garavalia, B., Spertus, J. A., & Decker, C. (2009) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181ae7b2a · Cited by 64

2019 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Mitral Valve Intervention

Bonow, R. O., O’Gara, P. T., Adams, D. H., Badhwar, V., Bavaria, J. E., Elmariah, S., Hung, J., Lindenfeld, J., Morris, A. A., Satpathy, R., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.002 · Cited by 62

Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure

Gourzoulidis, G., Kourlaba, G., Stafylas, P., Giamouzis, G., Parissis, J., & Maniadakis, N. (2017) · Health Policy · doi:10.1016/j.healthpol.2017.02.008 · Cited by 62

The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice

Chin, K. L., Skiba, M. A., Tonkin, A. M., Reid, C. M., Liew, D., Krum, H., & Hopper, I. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9575-2 · Cited by 55

Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction

Khariton, Y., Fonarow, G. C., Arnold, S. V., Hellkamp, A. S., Nassif, M. E., Sharma, P. P., Butler, J., Thomas, L. E., Duffy, C. I., DeVore, A. D., et al. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.05.016 · Cited by 55

Pharmacist- and Nurse-Led Medical Optimization in Heart Failure: A Systematic Review and Meta-Analysis

Zheng, J., Mednick, T., Heidenreich, P. A., & Sandhu, A. T. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2023.03.012 · Cited by 55

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction

Brownell, N. K., Ziaeian, B., & Fonarow, G. C. (2021) · Cardiac failure review · doi:10.15420/cfr.2021.18 · Cited by 54

Racial/Ethnic and Gender Disparities in Heart Failure with Reduced Ejection Fraction

Mwansa, H., Lewsey, S. C., Mazimba, S., & Breathett, K. K. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00502-5 · Cited by 53

Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF

Felker, G. M., Butler, J., Ibrahim, N. E., Piña, I. L., Maisel, A. S., Bapat, D., Camacho, A., Ward, J. H., WILLIAMSON, K. M., Solomon, S. D., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.054034 · Cited by 53

mHealth Interventions for Exercise and Risk Factor Modification in Cardiovascular Disease

Maddison, R., Rawstorn, J. C., Islam, S. M. S., Ball, K., Tighe, S. A., Gant, N., Whittaker, R., & Chow, C. K. (2019) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000185 · Cited by 52

Triage of Patients With Moderate to Severe Heart Failure

Thorvaldsen, T., Benson, L., Ståhlberg, M., Dahlström, U., Edner, M., & Lund, L. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.017 · Cited by 52

Outpatient Management of Heart Failure During the COVID-19 Pandemic After Adoption of a Telehealth Model

Sammour, Y. M., Spertus, J. A., Austin, B. A., Magalski, A., Gupta, S. K., Shatla, I. M., Dean, E., Kennedy, K. F., Jones, P. G., Nassif, M. E., et al. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2021.07.003 · Cited by 52

Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee

Colvin, M. M., Sweitzer, N. K., Albert, N. M., Krishnamani, R., Rich, M. W., Stough, W. G., Walsh, M. N., Canary, C. A. W., Allen, L. A., Bonnell, M. R., et al. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.05.013 · Cited by 50

Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function

Chatur, S., Vaduganathan, M., Claggett, B. L., Causland, F. R. M., Desai, A. S., Jhund, P. S., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.026 · Cited by 50

The Mortality Risk of Deferring Optimal Medical Therapy in Heart Failure: A Systematic Comparison Against Norms for Surgical Consent and Patient Information Leaflets

Zaman, S. U., Zaman, S., Scholtes, T., Shun-Shin, M. J., Plymen, C. M., Francis, D. P., & Cole, G. D. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.838 · Cited by 49

Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study

Januzzi, J. L., Omar, A. M. S., Liu, Y., Murphy, S., Butler, J., Felker, G. M., Piña, I. L., Ward, J. H., Solomon, S. D., & Contreras, J. (2022) · Circulation · doi:10.1161/circulationaha.122.061693 · Cited by 49

Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial

Böhm, M., Anker, S. D., Mahfoud, F., Lauder, L., Filippatos, G. S., Ferreira, J. P., Pocock, S., Brueckmann, M., Saloustros, I. G., Schueler, E., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac693 · Cited by 48

Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories

Butler, J., Packer, M., Siddiqi, T. J., Böhm, M., Brueckmann, M., Januzzi, J. L., Verma, S., Gergei, I., Iwata, T., Wanner, C., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.390 · Cited by 47

Feasibility of Telerehabilitation for Heart Failure Patients Inaccessible for Outpatient Rehabilitation

Lundgren, K. M., Langlo, K. A. R., Salvesen, Ø. O., Zanaboni, P., Cittanti, E., Mo, R., Ellingsen, Ø., Dalen, H., & Aksetøy, I. A. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14405 · Cited by 47

Four-Variable Risk Model in Men and Women With Heart Failure

Chyu, J., Fonarow, G. C., Tseng, C. H., & Horwich, T. B. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000404 · Cited by 47

HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America

Bozkurt, B., Ahmad, T., Alexander, K. M., Baker, W. L., Bosak, K., Breathett, K. K., Carter, S. J., Drazner, M. H., Dunlay, S. M., Fonarow, G. C., et al. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.07.001 · Cited by 456

Heart failure with preserved ejection fraction

HAMO, C. E., DeJong, C., Hartshorne‐Evans, N., Lund, L. H., Shah, S. J., Solomon, S. D., & Lam, C. S. P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00540-y · Cited by 190

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026

American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s010 · Cited by 107

HF STATS 2025: Heart Failure Epidemiology and Outcomes Statistics An Updated 2025 Report from the Heart Failure Society of America

Fonarow, G. C., Ahmad, F. S., Ahmad, T. A., Albert, N. M., Alexander, K. M., Baker, W. L., Bozkurt, B., Breathett, K. K., Carter, S. J., Cheng, R. K.-H., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.07.007 · Cited by 103

2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update

Hollenberg, S. M., Stevenson, L. W., Ahmad, T., Bozkurt, B., Butler, J., Davis, L. L., Drazner, M. H., Kirkpatrick, J. N., Morris, A. A., Page, R. L., II, et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.002 · Cited by 82

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction

Maddox, T. M., Januzzi, J. L., Allen, L. A., Breathett, K. K., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Lindenfeld, J., Masoudi, F. A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.022 · Cited by 872

2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction

Kittleson, M. M., Panjrath, G. S., Amancherla, K., Davis, L. L., Deswal, A., Dixon, D. L., Januzzi, J. L., & Yancy, C. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.393 · Cited by 554

2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update

Hollenberg, S. M., Stevenson, L. W., Ahmad, T., Bozkurt, B., Butler, J., Davis, L. L., Drazner, M. H., Kirkpatrick, J. N., Morris, A. A., Page, R. L., II, et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.002 · Cited by 82

2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction

Yancy, C. W., Januzzi, J. L., Allen, L. A., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Jessup, M. L., Lindenfeld, J., Maddox, T. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.025 · Cited by 284

Management of Heart Failure With Preserved Ejection Fraction: 2026 ACC Expert Consensus Decision Pathway

Kittleson, M. D., Panjrath, G. S., Bates, K., Breathett, K. K., Dixon, D. L., Januzzi, J. L., & Mohammed, S. F. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.06.018 · Cited by 15